Energy Drinks: The New Eye-Opener For Adolescents

https://doi.org/10.1016/j.cpem.2007.12.002Get rights and content

The availability of caffeine-containing energy beverages, combined with aggressive marketing and “urban legend,” has promoted their widespread use, particularly among adolescents. The caffeine content of these products is presently unregulated. Rapid growth in the consumption of these supplements has resulted in increasing reports of caffeine poisoning. This article provides a review of caffeine's pharmacokinetics and describes the clinical manifestations and management of caffeine toxicity. Suggestions for future research are also offered.

Section snippets

Caffeine

The key ingredient in most energy drinks is caffeine, supplemented by a wide variety of amino acids, B vitamins, and herbal supplements [3]. Caffeine is found in a wide variety of beverages and pharmaceuticals, and has been called the most commonly used psychoactive substance in the world [4]. Major sources in the North American diet include coffee and tea for adults, and carbonated sodas, energy drinks, and chocolate for children and adolescents. A range of caffeine concentrations are found in

Guarana and Other Caffeine-Containing Ingredients

Guarana is derived from the seeds of Paullinia cupana, a South American plant known for its stimulant properties. Guarana contains large amounts of caffeine (4%-8%), theobromine, theophylline, and a high concentration of tannins [11]. Although caffeine concentration may vary widely in guarana preparations, 3 to 5 g of guarana provides approximately 250 mg of caffeine [12]. The effects of guarana ingestion are necessarily similar to caffeine; however, the duration of action may be much longer

Pharmacokinetics of Caffeine

Caffeine, or 1,3,7-trimethylxanthine, is rapidly and completely absorbed after oral ingestion, with nearly 100% bioavailability [34]. Ingested caffeine reaches peak plasma concentration within approximately 30 to 120 minutes, depending on gastric contents. Caffeine is 10% to 35% protein bound and is rapidly redistributed from blood to all tissues [35]. It readily crosses the blood-brain barrier and placenta, and can be found in breast milk 36, 37. Its volume of distribution is 0.61 L/kg [38].

Pharmacology

As a member of the methylxanthine family, caffeine is a structural analog of adenosine and a functional adenosine receptor antagonist [47]. Antagonism at presynaptic alpha-1 receptors leads to an increase in peripheral catecholamine release with subsequent activation of postsynaptic β-adrenergic receptors [48]. The resulting norepinephrine, dopamine, and serotonin release in the brain reverses the centrally mediated adenosine effects of sedation and anticonvulsant activity [6]. Caffeine also

Clinical Manifestations, Toxicity

In 2005, more than 4600 calls were made to the American Association of Poison Control Centers (Washington, DC) for questions regarding caffeine. Of those, 2600 involved patients younger than 19 years, and 2345 required treatment in a health care facility. There were no deaths attributed to caffeine in 2004 or 2005 50, 51. There are no available data on the proportion of these calls credited to energy drink use.

Most caffeine intoxications are mild; adverse effects, such as nausea and

Laboratory Findings

Hypokalemia is the sine qua non laboratory abnormality in caffeine intoxication. The presentation of vomiting, tachycardia, and hypokalemia should prompt a search for methylxanthine or other β-agonist exposure (ie, albuterol, clenbuterol). Hyperglycemia is common in caffeine toxicity, secondary to increased lipolysis, glycogenolysis, and gluconeogenesis [77]. Leukocytosis, mild metabolic acidosis, ketonuria, hypophosphatemia, and hypocalcemia have also been described [61].

Qualitative testing

Management

Treatment of patients with caffeine toxicity must begin with careful and immediate assessment of the patient's airway, breathing, and circulation. Intravenous access must be established and noninvasive monitoring devices used. Oxygen should be administered if necessary, and a fingerstick glucose level should be rapidly obtained. Serum electrolytes, including calcium and phosphorus, should be obtained. Serial electrocardiograms are indicated in any patient with palpitations, chest pain, or vital

Future Research

Several areas require investigation to further characterize the effects of long-term energy drink use in children and adolescents. One of the most worrisome is the combination of energy drinks with alcohol. Urban legend and pop culture have contributed to the mystique that energy drinks may prevent the depressant effects of intoxication when consumed with alcohol [99]. Instead, a recent study described no change in alcohol effects when combined with energy drinks [100]. The potential risk for

Summary

Clinicians should screen for energy drink use among their patients. Screening can identify symptoms related to toxicity and give patients greater understanding of the risks of high-dose and long-term energy drink use. When caffeine toxicity is suspected, immediate consultation with a regional poison control center or toxicologist is recommended. Clinicians should report all suspected cases of energy drink toxicity to a poison control center because the pooled data generated by poison control

Acknowledgments

The authors gratefully acknowledge the assistance of Dr Edward W. Boyer and Mr William B. Hendee in the preparation of the manuscript.

References (104)

  • S.J. Iyadurai et al.

    New-onset seizures in adults: possible association with consumption of popular energy drinks

    Epilepsy Behav

    (2007)
  • G.W. Josephson et al.

    Caffeine intoxication: a case of paroxysmal atrial tachycardia

    JACEP

    (1976)
  • J. Forman et al.

    Myocardial infarction resulting from caffeine overdose in an anorectic woman

    Ann Emerg Med

    (1997)
  • K.D. Wrenn et al.

    Rhabdomyolysis induced by a caffeine overdose

    Ann Emerg Med

    (1989)
  • C.C. Appel et al.

    Caffeine-induced hypokalemic paralysis in pregnancy

    Obstet Gynecol

    (2001)
  • J. Golej et al.

    Severe respiratory failure following charcoal application in a toddler

    Resuscitation

    (2001)
  • R.V. Nagesh et al.

    Caffeine poisoning treated by hemoperfusion

    Am J Kidney Dis

    (1988)
  • K. Price et al.

    Treatment of caffeine toxicity with esmolol

    Ann Emerg Med

    (1990)
  • V.E. Whitehurst et al.

    Reversal of acute theophylline toxicity by calcium channel blockers in dogs and rats

    Toxicology

    (1996)
  • K.V. Blake et al.

    Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline-induced seizures in mice

    Ann Emerg Med

    (1988)
  • A. Hoffman et al.

    Effect of pretreatment with anticonvulsants on theophylline-induced seizures in the rat

    J Crit Care

    (1993)
  • G.A. Bernstein et al.

    Caffeine withdrawal in normal school-age children

    J Am Acad Child Adolesc Psychiatry

    (1998)
  • N. Shute

    Over the limit?. US News and World Report

  • Foxnews.com

    Teens abusing energy boosting drinks, doctors fear

  • L. Dlugosz et al.

    Reproductive effects of caffeine: a review and theoretical analysis

    Epidemiol Rev

    (1992)
  • R. Gilbert et al.

    Caffeine content of beverages as consumer

    Can Med Assoc J

    (1976)
  • P. Nawrot et al.

    Effects of caffeine on human health

    Food Addit Contam

    (2003)
  • N.L. Benowitz

    Clinical pharmacology of caffeine

    Annu Rev Med

    (1990)
  • J.R. Hughes et al.

    A systematic survey of caffeine intake in Vermont

    Exp Clin Psychopharmacol

    (1997)
  • Health Canada

    It's your health: caffeine

  • R.R. McCusker et al.

    Caffeine content of energy drinks, carbonated sodas, and other beverages

    J Anal Toxicol

    (2006)
  • Guarana. In: AltMedDex System [intranet database]. Greenwood Village CVG (Colo): Thomson Micromedex; 2007. Available...
  • Food Safety Promotion of Board

    A review of the health effects of stimulant drinks: a final report from the Food Safety Promotion Board

  • C.F. Haskell et al.

    A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guarana in humans

    J Psychopharmacol

    (2007)
  • W.C. Heird

    Taurine in neonatal nutrition—revisited

    Arch Dis Child Fetal Neonatal Ed

    (2004)
  • M.L. MacDonald et al.

    Nutrition of the domestic cat, a mammalian carnivore

    Annu Rev Nutr

    (1984)
  • J.T. Coon et al.

    Panax ginseng: a systematic review of adverse effects and drug interactions

    Drug Saf

    (2002)
  • E. Ernst

    The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

    Ann Intern Med

    (2002)
  • C.A. Ries et al.

    Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone

    JAMA

    (1975)
  • K. Janetzky et al.

    Probable interaction between warfarin and ginseng

    Am J Health Syst Pharm

    (1997)
  • R.K. Siegel

    Ginseng abuse syndrome. Problems with the panacea

    JAMA

    (1979)
  • S. Braganza et al.

    Riding high on energy drinks. Modern medicine

  • P.E. Lheureux et al.

    Science review: carnitine in the treatment of valproic acid-induced toxicity—what is the evidence?

    Crit Care

    (2005)
  • S. Russell

    Carnitine as an antidote for acute valproate toxicity in children

    Curr Opin Pediatr

    (2007)
  • Carnitor

    Carnitor (levocarnitine) tablets and oral solution, and Carnitor SF sugar-free oral solution package insert

  • M. Soop et al.

    Influence of carnitine supplementation on muscle substrate and carnitine metabolism during exercise

    J Appl Physiol

    (1988)
  • J. Decombaz et al.

    Muscle carnitine after strenuous endurance exercise

    J Appl Physiol

    (1992)
  • E. Brass

    Supplemental carnitine and exercise

    Am J Clin Nutr

    (2000)
  • Bodybuilding.com

    l-Carnitine information and product listing: an amino acid that helps with fat loss

  • M.J. Arnaud

    The pharmacology of caffeine

    Prog Drug Res

    (1987)
  • Cited by (123)

    • Caffeinated energy drink consumption and predictors of use among secondary school students over time in the COMPASS cohort study

      2019, Preventive Medicine Reports
      Citation Excerpt :

      Caffeinated energy drinks (CEDs) commonly contain a moderate to high level of caffeine, stimulating herbal supplements, and sugar or sugar derivatives (McCusker et al., 2006; Health Canada, 2015a). Evidence suggests that within the CED market, nearly half of consumers are 25 years of age or younger (Pomeranz et al., 2013; Babu et al., 2008; Clauson et al., 2008). While Health Canada recommends limiting daily caffeine intake among adolescents to ≤2.5 mg/kg body weight, it has been reported that the typical CED available in the Canadian market contains between 80 and 180 mg of caffeine (Health Canada, 2013; Health Canada, 2015b).

    • Energy drink consumption among German adolescents: Prevalence, correlates, and predictors of initiation

      2019, Appetite
      Citation Excerpt :

      Energy drinks (ED) are beverages that contain high levels of caffeine in combination with other ingredients such as amino acids, sugars or sweeteners, guarana, taurine, ginseng, l-carnitine, herbal supplements, and B vitamins (Babu, Church, & Lewander, 2008; McCusker, Goldberger, & Cone, 2006; Reissig, Strain, & Griffiths, 2009; Seifert, Schaechter, Hershorin, & Lipshultz, 2011).

    View all citing articles on Scopus
    View full text